★
ASPI
ASP Isotopes Inc · Chemicals
FCF-$66mF
Rev+511.2%A
D/E0.07A
P/S38.9xD
PEG——
59Score
$7.551Y Target$10.19Near-term target
5Y Target$15.19Compound horizon
10Y Target$39.52Long-dated conviction
FCF-$66mTTM · 03/26F
FCF is negative (-$66m) — cash-burning phase; acceptable only for pre-profit spec names · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+511.2%TTM YoYA
Revenue +511.2% — hypergrowth, top decile
D/E0.07totalA
D/E 0.07 — essentially debt-free, pristine balance sheet · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S38.9xD
P/S 38.9x — extreme, prices in flawless execution
PEG—proxy—
PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Entry · Margin of safety
52-week rangeMid-range
48% off the 12-month high
Why now
Chemicals · market cap $1.0b. Down 48% from 52-week high of $14.49 — deep drawdown territory. Revenue growing +511% — in hypergrowth territory.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Free cash flow is negative (-$66m) — capital raises or debt issuance likely required; dilution / leverage risk. Currently unprofitable (margin -644.4%) — path to GAAP profitability is the core thesis risk. Down 48% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Horizon
1-3 yr $10.19 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $15.19 — requires the platform / technology to reach commercial scale. 10 yr $39.52 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · ASPI
Shares to buy
264
Position size
$1,993
4.0% of portfolio
Stop price
$5.66
25% below $7.55
$ at risk
$500.00
1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.